• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中的大汗淋漓作为一种撤药现象:治疗及其与血浆左旋多巴水平的关系

Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profile.

作者信息

Sage J I, Mark M H

机构信息

Department of Neurology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick 08903.

出版信息

Ann Neurol. 1995 Jan;37(1):120-2. doi: 10.1002/ana.410370124.

DOI:10.1002/ana.410370124
PMID:7818245
Abstract

We followed 4 patients with Parkinson's disease and severe, intermittent, drenching sweats. One patient was studied with serial plasma levodopa levels and simultaneous clinical examinations. She was observed during a severe sweating episode; this was associated with subtherapeutic plasma levodopa levels (low dopa state). All 4 patients' sweats responded favorably to the institution of agonist therapy. Drenching sweats should be considered part of the spectrum of off-period levodopa-related fluctuations in Parkinson's disease.

摘要

我们跟踪了4例患有帕金森病且伴有严重、间歇性大汗淋漓症状的患者。对其中1例患者进行了系列血浆左旋多巴水平测定及同步临床检查。在一次严重出汗发作期间对她进行了观察;这与血浆左旋多巴水平低于治疗量(低多巴状态)有关。所有4例患者的出汗症状在开始使用激动剂治疗后均有良好反应。大汗淋漓应被视为帕金森病中与左旋多巴停药期相关波动症状谱的一部分。

相似文献

1
Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profile.帕金森病中的大汗淋漓作为一种撤药现象:治疗及其与血浆左旋多巴水平的关系
Ann Neurol. 1995 Jan;37(1):120-2. doi: 10.1002/ana.410370124.
2
Pergolide and Parkinson's disease: new preparation. No clear benefit.培高利特与帕金森病:新制剂。无明确益处。
Prescrire Int. 2000 Dec;9(50):177-9.
3
[Pergolide: a useful agonist for the treatment of Parkinson disease].培高利特:治疗帕金森病的一种有效激动剂
Rev Neurol (Paris). 2002 Jul;158(6-7):744-5.
4
Cabergoline improves motor disability without modifying L-dopa plasma levels in fluctuating Parkinson's disease patients.卡麦角林可改善波动性帕金森病患者的运动功能障碍,而不改变其血浆左旋多巴水平。
J Neural Transm Suppl. 1995;45:259-65.
5
Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.晚期帕金森病的严重夜间异动症:临床描述、与血浆左旋多巴的关系及治疗
Mov Disord. 1994 Mar;9(2):173-7. doi: 10.1002/mds.870090208.
6
A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine.一种“联合”左旋多巴试验作为评估多巴胺激动剂疗效的有用方法:在培高利特和溴隐亭中的应用
Mov Disord. 1995 Sep;10(5):668-71. doi: 10.1002/mds.870100522.
7
Benefits of monitoring plasma levodopa in Parkinson's disease patients with drug-induced chorea.
Ann Neurol. 1991 Jun;29(6):623-8. doi: 10.1002/ana.410290609.
8
DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.多巴胺激动剂——麦角衍生物:溴隐亭:帕金森病的治疗
Mov Disord. 2002;17 Suppl 4:S53-67. doi: 10.1002/mds.5562.
9
Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study.培高利特与溴隐亭治疗帕金森病的比较:一项多中心、交叉、对照研究。
Mov Disord. 1994 Jul;9(4):431-6. doi: 10.1002/mds.870090409.
10
Conversion from dopamine agonists to cabergoline: an open-label trial in 128 patients with advanced Parkinson disease.从多巴胺激动剂转换为卡麦角林:一项针对128例晚期帕金森病患者的开放标签试验。
Clin Neuropharmacol. 2008 Jan-Feb;31(1):19-24. doi: 10.1097/wnf.0b013e318067bcc4.

引用本文的文献

1
Epidemiology of autonomic dysfunction in Parkinson's disease (Review).帕金森病自主神经功能障碍的流行病学(综述)
Med Int (Lond). 2025 Sep 1;5(6):68. doi: 10.3892/mi.2025.267. eCollection 2025 Nov-Dec.
2
Autonomic Dysfunctions in Parkinson's Disease: Prevalence, Clinical Characteristics, Potential Diagnostic Markers, and Treatment.帕金森病中的自主神经功能障碍:患病率、临床特征、潜在诊断标志物及治疗
Parkinsons Dis. 2020 Dec 24;2020:8740732. doi: 10.1155/2020/8740732. eCollection 2020.
3
Autonomic Dysfunction in Parkinson's Disease.
帕金森病的自主神经功能障碍。
Neurotherapeutics. 2020 Oct;17(4):1464-1479. doi: 10.1007/s13311-020-00897-4.
4
The Skin and Parkinson's Disease: Review of Clinical, Diagnostic, and Therapeutic Issues.皮肤与帕金森病:临床、诊断及治疗问题综述
Mov Disord Clin Pract. 2016 Sep 8;4(1):21-31. doi: 10.1002/mdc3.12425. eCollection 2017 Jan-Feb.
5
Sweating dysfunctions in Parkinson's disease.帕金森病中的出汗功能障碍
J Neurol. 2006 Dec;253 Suppl 7:VII42-47. doi: 10.1007/s00415-006-7010-7.
6
Autonomic Nervous System Dysfunction in Parkinson's Disease.帕金森病中的自主神经系统功能障碍
Curr Treat Options Neurol. 2003 Mar;5(2):149-160. doi: 10.1007/s11940-003-0005-0.